| scholarly article | Q13442814 |
| P2093 | author name string | Corinne Haioun | |
| Jean-François Deux | |||
| Alain Rahmouni | |||
| Alain Luciani | |||
| Charles A Cuenod | |||
| Chieh Lin | |||
| Frédérique Kuhnowski | |||
| Karim Belhadj | |||
| Mezri Maatouk | |||
| Pauline Beaussart | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple myeloma | Q467635 |
| P304 | page(s) | 521-531 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging | |
| P478 | volume | 254 |
| Q43672014 | (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment |
| Q82662393 | 18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation |
| Q89919144 | Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI |
| Q48262403 | Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology |
| Q36366654 | Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma |
| Q44627038 | Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation |
| Q49986545 | Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma |
| Q36457735 | Current and future imaging modalities for multiple myeloma and its precursor states |
| Q47834399 | Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation |
| Q33881446 | Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology |
| Q26864616 | Imaging of multiple myeloma: Current concepts |
| Q26750794 | MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings |
| Q37924047 | Modern imaging techniques during therapy in patients with multiple myeloma |
| Q39250961 | Multiple myeloma of the spine |
| Q46690536 | Non-Secretory Myeloma: Ready for a new Definition? |
| Q28074785 | Non-secretory multiple myeloma: from biology to clinical management |
| Q89450442 | Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response |
| Q38033606 | The role of imaging techniques in the management of multiple myeloma |
| Q37676265 | The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma. |
| Q82587084 | The year in review: recent advances in musculoskeletal radiology and biology |
| Q35148900 | Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI. |
| Q39233116 | Total variation-based method for generation of intravoxel incoherent motion parametric images in MRI. |
| Q33711291 | Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis. |
| Q37593761 | Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response |
| Q45929472 | Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study. |
| Q47107000 | Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction |
| Q39176990 | Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma |
| Q60714624 | Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses |
| Q84318611 | [Whole body functional MR imaging: hemato-oncologic applications] |
Search more.